MONHEIM / Germany, 29 April 2025: Bayer today announced the appointment of Guru Ramamurthy as the new Chief Financial Officer (CFO) of its Crop Science division, effective July 1, 2025. Ramamurthy, currently serving as CFO of Bayer US, will succeed Oliver Rittgen, who is departing the company after 25 years to pursue new opportunities.
With over two decades at Bayer, Guru Ramamurthy brings a deep well of financial leadership, strategic insight, and a reputation for enabling business transformation and driving profitability across global markets. His track record spans key finance roles across Germany, Italy, Japan, and the United States. He has also served as CFO of AskBio, Bayer’s gene therapy subsidiary, and as Global CFO of Bayer’s Medical Care division.
“Guru has a strong track record of enabling business turnarounds and shaping strategies that enhance growth and deliver results,” said Rodrigo Santos, Member of the Board of Bayer AG and President of the Crop Science Division. “His collaborative and innovative approach makes him the right leader for this role.”
Ramamurthy will be based in St. Louis, Missouri, as he takes charge of Bayer’s financial operations in the agriculture-focused Crop Science division. A successor for his current U.S. role will be announced soon.
Departing CFO Oliver Rittgen has served in various corporate finance and regional leadership roles since joining Bayer in 2000. Most recently, he held CFO roles for both the Crop Science and Consumer Health divisions.
“Oliver’s entrepreneurial thinking and leadership have been instrumental in shaping Bayer’s financial direction. We are grateful for his significant contributions and wish him continued success,” added Santos.
The leadership change signals Bayer’s continued focus on strengthening its global business performance, innovation, and long-term strategic growth within the agriculture and life sciences sectors.
